Loading clinical trials...
Loading clinical trials...
Investigate the efficacy and safety of ONO-4538 in patients with Richter's transformation
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Ono Pharmaceutical Co. Ltd
NCT03162536 · Lymphoma, B-Cell, Small Lymphocytic Lymphoma, and more
NCT04305444 · Relapsed Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia, and more
NCT02378038 · Richter's Transformation
NCT03778073 · B-cell Non Hodgkin Lymphoma, Richter's Transformation
NCT03153514 · Chronic Lymphocytic Leukemia, Richter's Transformation
Aichi Cancer Center
Nagoya, Aichi-ken
Kyusyu University Hospital
Fukuoka, Fukuoka
Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital
Hiroshima, Hiroshima
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions